Comparing pregnancy outcomes with and without Glucophage in women with PCOS
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at whether taking a medicine called Glucophage (also known as metformin) during pregnancy can improve pregnancy outcomes for women who have polycystic ovary syndrome (PCOS). The researchers will compare the results of women who take Glucophage with those who do not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- You are pregnant with one baby (not twins or more)
- You have been diagnosed with PCOS before getting pregnant
- You are in your first trimester (up to 13 weeks of pregnancy) when you first see the doctor
- You do not have pre-eclampsia, gestational diabetes, or high blood pressure
- You are not already taking Glucophage or metformin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines—dapagliflozin and metformin—to see which works better for women with PCOS who are trying to get pregnant. Both drugs may help improve hormone balance and ovulation, but they work differently.
This trial compares two medicines, vildagliptin and metformin, to see which is better at helping women with polycystic ovary syndrome (PCOS) get pregnant. It is for women who are struggling to conceive and do not have diabetes.
This study is testing different ways of using the medicine metformin to help women with PCOS manage their symptoms and improve their health. If you are overweight and have PCOS, this trial may help find the best dose for you.
This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.
This study tests whether a class of diabetes drugs called GLP-1 receptor agonists can improve fertility in overweight women with polycystic ovary syndrome who want to conceive. These drugs help with weight and blood sugar, which may improve ovulation and pregnancy chances.
This study looks at how women with PCOS process sugar after drinking a glucose solution, compared to women without PCOS. Researchers measure blood and metabolic changes to understand the condition better, which could help shape future treatments.
Hear when a new Polycystic Ovarian Syndrome (PCOS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.